Pharmaceuticals Market Research Reports & Industry Analysis
Pharmaceuticals Industry Research & Market Reports
-
Mental Health & Substance Abuse Services
... include Acadia Healthcare, Hazelden Betty Ford Foundation, and Spectrum Health Systems (all based in the US), along with the Centre for Addiction and Mental Health (Canada), and the Crossroads Centre (Antigua). COMPETITIVE LANDSCAPE Demand for ... Read More
-
Marijuana Stores
... The multibillion-dollar global industry is experiencing strong growth, though the newness of the market and variance in regulation across geographies creates major barriers to entry. The industry includes medical marijuana dispensaries and stores that sell ... Read More
-
LIQUID BIOPSY MARKETS by Cancer Type by Diagnosis, Monitoring & Recurrence Testing. 2019-2023 w. Historical Data Including Screening Market Potential Size with Executive and Consultant Guides
... in vitro blood testing to identify cancer DNA. The technology creates new markets for cancer screening tests. GRAIL, a new company with impressive backing, has announced a single blood test to detect all cancers. The ... Read More
-
Global Influenza Vaccines Market, Persons Vaccinated, Brand Analysis, Size, Share, Growth, Trends, Major Deals - Forecast to 2024
... is presenting ample opportunities to the industry’s players. Influenza viruses are considered as a major cause of morbidity and mortality worldwide. The vast population base together with significantly low vaccination coverage in emerging markets, introduction ... Read More
-
Chemical Company of Malaysia Berhad (CCM) - Financial and Strategic SWOT Analysis Review
... to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling ... Read More
-
Athersys Inc (ATHX) - Financial and Strategic SWOT Analysis Review
... you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand ... Read More
-
Neos Therapeutics Inc (NEOS) - Financial and Strategic SWOT Analysis Review
... to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to ... Read More
-
BELLUS Health Inc (BLU) - Financial and Strategic SWOT Analysis Review
... to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to ... Read More
-
Ligand Pharmaceuticals Inc (LGND) - Financial and Strategic SWOT Analysis Review
... to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to ... Read More
-
Magellan Health Inc (MGLN) - Financial and Strategic SWOT Analysis Review
... to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to ... Read More
-
Evotec AG (EVT) - Financial and Strategic SWOT Analysis Review
... you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand ... Read More
-
Imprimis Pharmaceuticals Inc (IMMY) - Financial and Strategic SWOT Analysis Review
... to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to ... Read More
-
Qatar Pharmaceuticals & Healthcare Q3 2018
... government’s commitment towards promoting the developmentof the healthcare sector will support this trend. While local drug manufacturing capacity will continue to increase, Qatar will remaindependent on pharmaceutical imports over the foreseeable future. Despite the favourable ... Read More
-
Global Pharmaceuticals & Medicine Manufacturing - Industry Market Research Report
... customer base for industry operators. Many manufacturers also tapped into regional demand for pharmaceuticals that may differ from developed markets. Furthermore, the growing global middle class provides additional growth opportunities, given increased access to pharmaceutical ... Read More
-
Philippines Pharmaceuticals & Healthcare Q3 2018
... disease profile will continue to evolve in line with economic anddemographic trends and will provide a number of revenue earning opportunities for pharmaceutical firms, a multitude of regulatoryissues will create challenges while policies implemented to ... Read More
-
Jordan Pharmaceuticals & Healthcare Q3 2018
... diseases among the population. Meanwhile, we expectthe government to maintain a positive business environment for the pharmaceutical industry due to its strategic importance toJordan's economy, ensuring that the country remains a net exporter of medicines. Read More
-
Panama Pharmaceuticals & Healthcare Q3 2018
... market, Panama will continue to attract interestfrom foreign pharmaceutical companies, reinforcing its role as a re-export hub of pharmaceuticals to the Latin American region.Although Panama's economic growth and, therefore, healthcare spending headlines will remain vulnerable ... Read More
-
Spain Pharmaceuticals & Healthcare Q3 2018
... Spain’s out-of-pocket expenditure onhealth is well above the EU average, a result of health reforms which shifted some of the costs for healthcare and medicine ontohouseholds. These trends, combined with the forecasted economic slowdown in ... Read More
-
2018 Supplement Business Report
... to boost sales growth overall. Collagen is on fire, growing at 30 percent, but it hasn’t broken the $100 million barrier yet, coming in at $98 million. Mushrooms had another strong year at 10.1 percent ... Read More
-
Asia Pharmaceuticals & Healthcare Q3 2018
... the smaller, underdeveloped pharmaceutical markets willpresent the weakest commercial incentives owing to their relative market size and level of pharmaceutical development. Highergrowth opportunities in the smaller emerging markets will present themselves within the generic medicines ... Read More
-
Russia Pharmaceuticals & Healthcare Q3 2018
... policy continuity will lead toincreased investment in localised drug production in the market, although this will remain heavily weighted towards the genericmedicines sector given the continued regulatory issues and market access barriers for innovative drugmakers. Read More
-
Europe Pharmaceuticals & Healthcare Q3 2018
... to region-specific trends. Themore developed Western markets will continue to be favoured by innovative drugmakers due to stronger regulatory oversight andgreater purchasing power, although growth in these markets will be suppressed by aggressive cost-containment. Revenue ... Read More
-
Tunisia Pharmaceuticals & Healthcare Q3 2018
... expect it to retain this position over the long term. Highlighting themarket's longer-term potential, some multinational drugmakers have shown their willingness to do business in the country, thoughthe majority choose to operate indirectly to minimise ... Read More
-
Sub-Saharan Africa Pharmaceuticals & Healthcare Q3 2018
... procedures, a lack of enforced patent laws, and ageneral lack of transparency that ensures the region lags behind others globally for revenue-earning opportunities. Despite this, theregion's pharmaceutical markets will continue to provide long-term opportunities for ... Read More
-
2018 US Hematology and Flow Cytometry Analyzers and Reagents: Supplier Sales and Shares, Sales Segment Forecasts - Hospitals, Commercial Laboratories, POC Locations - Competitive Landscape, Emerging Technologies, Instrumentation Review
... 306 pages, 59 tables, and is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in US hematology and flow cytometry hospital, commercial and point-of-care/POC markets during the next ... Read More
